Mosquito cells bind and replicate hepatitis C virus

Journal of Medical Virology

Volumn 64, Issue 1, 2001, Pages 6-12

  Germi, Raphaële ^a   Crance, Jean Marc ^b   Garin, Daniel ^b   Guimet, Josette ^a   Thelu, Marie Ange ^c   Jouan, Alain ^b   Zarski, Jean Pierre ^c   Drouet, Emmanuel ^a  

^a Faculté de Médecine Pharmacie de Grenoble   (France)

^b CRSSA Emile Pardé de Grenoble   (France)

^c GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

Cell culture; Hepatitis C; Virus replication

Indexed keywords

CD81 ANTIGEN; VIRUS RECEPTOR; VIRUS RNA;

AEDES; AEDES PSEUDOSCUTELLARIS; ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; CYTOFLUOROMETRY; HEPATITIS C VIRUS; HEPATOMA CELL; HUMAN; HUMAN CELL; LYMPHOMA CELL; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VERO CELL; VIRUS ADSORPTION; VIRUS CELL INTERACTION; VIRUS LOAD; VIRUS REPLICATION;

CERCOPITHECUS AETHIOPS; HEPATITIS C VIRUS;

EID: 0035085321     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.1010     Document Type: Article

References (38)

1. Hepatitis C virus and other Flaviviridae viruses enter cells via low density lipoprotein receptor
2. Epidemiology of hepatitis C
3. The human bone-marrow-derived B-cell line CE, susceptible to hepatitis C virus infection
4. Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate
5. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome
6. Characterization of hepatitis C virus E2 glycoprotein interaction with a putative cellular receptor, CD81
7. Functional characterization of intracellular and secreted forms of truncated hepatitis C virus E2 glycoprotein
8. Enhanced detection by PCR of hepatitis C virus RNA
9. Suramin blocks hepatitis C Binding to human hepatoblastoma cells in vitro
10. Quantification of hepatitis C virus RNA production in two human bone marrow-derived B-cell lines infected in vitro
11. Human hepatocyte clonal cell lines that support persistent replication of hepatitis C virus
12. Replication of hepatitis C virus in cultured non-neoplastic human hepatocytes
13. Susceptibility of human T-lymphotropic virus type I infected cell line MT-2 to hepatitis C virus infection
14. Systems to culture hepatitis C virus
15. Lack of detection of negative-strand hepatitis C virus RNA in peripheral blood mononuclear cells and other extrahepatic tissues by the highly strand-specific rTth reverse transcriptase PCR
16. CD81 (TAPA-1): A molecule involved in signal transduction and cell adhesion in the immune system
17. Long-term follow-up of chronic post transfusion non-A, non-B hepatitis: Clinical and histological out-com
18. Long-term human T-cell culture system supporting hepatitis C virus replication
19. Characterization of hepatitis C virus replication in cloned cells obtained from a human T-cell leukemia virus type I-infected cell line, MT-2
20. Low density lipoprotein receptor as a candidate receptor for hepatitis C virus
21. Flavivirus
22. Characterization of long-term culture of hepatitis C virus
23. RNA in the liver of chronic hepatitis C patients by strand-specific semiquantitative reverse-transcriptase polymerase chain reaction
24. The 5′-terminal sequence of the hepatitis C virus genome
25. Binding of hepatitis C virus to CD81
26. Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: Effects of dose and duration
27. Randomized trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks vs. interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus
28. Flaviviridae: The viruses and their replication
29. Is CD81 the key to hepatitis C virus entry?
30. Multiplication of viruses: An overview
31. A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: Cytofluorometric assessment of the envelope glycoprotein 2 binding to the target cells. 1996
32. Establishment of persistent hepatitis C virus infection and replication in vitro
33. Evidence for in vitro replication of hepatitis C virus genome in a human T-cell line
34. Correlation between the infectivity of hepatitis C virus in vivo and its infectivity in vitro
35. Multicycle infection of hepatitis C virus in cell culture and inhibition by α and β interferon
36. Infection of human hepatocytes cell lines with hepatitis C virus in vitro
37. Hepatitis C virus infection of a Vero cell clone displaying efficient virus-cell binding
38. Tenoxicam, a non-steroid anti-inflammatory drug, is unable to increase the response rate in patients with chronic hepatitis C treated by alpha interferon